Global medical cannabis market projected to reach $33.2 billion by 2027
Bethan Rose Jenkins, Cannabis News Writer/Editorial
• November 14, 2021
Tilray reports annual loss of $336 million, $4 billion in cannabis sales expected by 2024
Bethan Rose Jenkins, Cannabis News Writer/Editorial
• August 26, 2021
COVID-19 impact and global analysis: Medical cannabis market will inflate at 23.9 percent CAGR by 2028
Bethan Rose Jenkins, Cannabis News Writer/Editorial
• July 12, 2021
Four cannabis stocks worth the investment this summer
Bethan Rose Jenkins, Cannabis News Writer/Editorial
• June 15, 2021
Canadian cannabis firm Tilray reports $341 million net loss in last quarter
Bethan Rose Jenkins, Cannabis News Writer/Editorial
• May 31, 2021
Cannabis stocks shift north after Biden’s win
Bethan Rose Jenkins, Cannabis News Writer/Editorial
• November 15, 2020
Increasing number of EU-GMP certifications being awarded to Canadian cannabis companies
Bethan Rose Jenkins, Cannabis News Writer/Editorial
• March 24, 2020
Coronavirus and cannabis: China’s supply shutdown is impacting vape businesses and events
Bethan Rose Jenkins, Cannabis News Writer/Editorial
• March 16, 2020
Tilray and Cronos report decline in per-gram weed prices
Bethan Rose Jenkins, Cannabis News Writer/Editorial
• December 2, 2019
Tilray signs deal to purchase Canadian adult-use cannabis retailer
Bethan Rose Jenkins, Cannabis News Writer/Editorial
• September 30, 2019
Cannabis cultivation market will soar to $45.4 billion by 2026
Bethan Rose Jenkins, Cannabis News Writer/Editorial
• September 25, 2019
Cannabis firm Tilray is hiring Goldman Sachs’ former managing director
Bethan Rose Jenkins, Cannabis News Writer/Editorial
• March 28, 2019
Load More Stories